CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

por Garutti, Mattia, Targato, Giada, Buriolla, Silvia, Palmero, Lorenza, Minisini, Alessandro Marco, Puglisi, Fabio
Publicado 2021

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma

por Garutti, Mattia, Bonin, Serena, Buriolla, Silvia, Bertoli, Elisa, Pizzichetta, Maria Antonietta, Zalaudek, Iris, Puglisi, Fabio
Publicado 2021

“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers

por Garutti, Mattia, Buriolla, Silvia, Bertoli, Elisa, Vitale, Maria Grazia, Rossi, Ernesto, Schinzari, Giovanni, Minisini, Alessandro Marco, Puglisi, Fabio
Publicado 2020

Immunotherapy in NSCLC Patients with Brain Metastases

por Buriolla, Silvia, Pelizzari, Giacomo, Corvaja, Carla, Alberti, Martina, Targato, Giada, Bortolot, Martina, Torresan, Sara, Cortiula, Francesco, Fasola, Gianpiero, Follador, Alessandro
Publicado 2022

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

por Gerratana, Lorenzo, Basile, Debora, Franzoni, Alessandra, Allegri, Lorenzo, Viotto, Davide, Corvaja, Carla, Bortot, Lucia, Bertoli, Elisa, Buriolla, Silvia, Targato, Giada, Da Ros, Lucia, Russo, Stefania, Bonotto, Marta, Belletti, Barbara, Baldassarre, Gustavo, Damante, Giuseppe, Puglisi, Fabio
Publicado 2020

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

por Basile, Debora, Gerratana, Lorenzo, Corvaja, Carla, Pelizzari, Giacomo, Franceschin, Giorgia, Bertoli, Elisa, Palmero, Lorenza, Zara, Diego, Alberti, Martina, Buriolla, Silvia, Da Ros, Lucia, Bonotto, Marta, Mansutti, Mauro, Spazzapan, Simon, Cinausero, Marika, Minisini, Alessandro Marco, Fasola, Gianpiero, Puglisi, Fabio
Publicado 2021